Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
CERESOLI, G. L, ZUCALI, P. A, SOTO-PARRA, H, DE VINCENZO, F, BRUZZONE, A, LORENZI, E, GIANONCELLI, L, ERCOLI, B, GIORDANO, L, SANTORO, A, MENCOBONI, M, BOTTA, M, GROSSI, F, CORTINOVIS, D, ZILEMBO, N, RIPA, C, TISEO, M, FAVARETTO, A. G
Published in British journal of cancer (06.08.2013)
Published in British journal of cancer (06.08.2013)
Get full text
Journal Article
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy
Santoro, A., Comandone, A., Basso, U., Soto Parra, H., De Sanctis, R., Stroppa, E., Marcon, I., Giordano, L., Lutman, F.R., Boglione, A., Bertuzzi, A.
Published in Annals of oncology (01.04.2013)
Published in Annals of oncology (01.04.2013)
Get full text
Journal Article
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy
Houédé, N, Locker, G, Lucas, C, Parra, H Soto, Basso, U, Spaeth, D, Tambaro, R, Basterretxea, L, Morelli, F, Theodore, C, Lusuardi, L, Lainez, N, Guillot, A, Tonini, G, Bielle, J, Del Muro, X Garcia
Published in BMC cancer (23.09.2016)
Published in BMC cancer (23.09.2016)
Get full text
Journal Article
Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study
SANTORO, A, BREDENFELD, H, BONADONNA, G, DIEHL, V, DEVIZZI, L, TESCH, H, BONFANTE, V, VIVIANI, S, FIEDLER, F, PARRA, H. S, BENOEHR, C, PACINI, M
Published in Journal of clinical oncology (01.07.2000)
Published in Journal of clinical oncology (01.07.2000)
Get full text
Journal Article
Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour
BERTUZZI, A, CASTAGNA, L, SARINA, B, SOTO PARRA, H, SANTORO, A, QUAGLIUOLO, V, GINANNI, V, COMPASSO, S, MAGAGNOLI, M, BALZAROTTI, M, NOZZA, A, SIRACUSANO, L, TIMOFEEVA, I
Published in British journal of cancer (06.10.2003)
Published in British journal of cancer (06.10.2003)
Get full text
Journal Article
Lessons from the 'Iressa' Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations
Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Published in British journal of cancer (01.12.2003)
Published in British journal of cancer (01.12.2003)
Get full text
Journal Article
EGFR mutational status in determining choice of TKIs or standard chemotherapy for patients with advanced non-small cell lung cancer
Motta, L., Motta, G., Banna, G., Martorana, F., Longhitano, C., Inzerilli, N., Restuccia, N., Aiello, M., Soto Parra, H.J., Vigneri, P.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Efficacy of ceritinib administered to patients with crizotinib-refractory, ALK-positive, advanced NSCLC within the Italian compassionate use program
Metro, G., Passaro, A., Lo Russo, G., Bonanno, L., Giusti, R., Gregorc, V., Capelletto, E., Martelli, O., Cecere, F.L., Giannarelli, D., Luciani, A., Bearz, A., Tuzi, A., Scotti, V., Tonini, G., Galetta, D., Carta, A., Soto Parra, H., Morabito, A., Chiari, R.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort
Passaro, A., Metro, G., Tiseo, M., Migliorino, M.R., Santo, A., Sperandi, F., Maione, P., Puppo, G., Grossi, F., Soto Parra, H.J., Borra, G., Roca, E., Rocco, D., Stasi, I., Galetta, D., Carta, A.M., Milella, M., Fasola, G., Gebbia, V., Ferrari, S., De Marinis, F.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Activity of a specific inhibitor, gefitinib (Iressa™, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer
Santoro, A., Cavina, R., Latteri, F., Zucali, P. A., Ginanni, V., Campagnoli, E., Ferrari, B., Morenghi, E., Pedicini, V., Roncalli, M., Alloisio, M., Ravasi, G., Soto Parra, H. J.
Published in Annals of oncology (01.01.2004)
Published in Annals of oncology (01.01.2004)
Get full text
Journal Article
Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study
Soto Parra, H., Cavina, R., Latteri, F., Sala, A., Dambrosio, M., Antonelli, G., Morenghi, E., Alloisio, M., Ravasi, G., Santoro, A.
Published in Annals of oncology (01.07.2002)
Published in Annals of oncology (01.07.2002)
Get full text
Journal Article
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease
BONFANTE, V, VIVIANI, S, SANTORO, A, DEVIZZI, L, DI RUSSO, A, ZANINI, M, SONCINI, F, SOTO PARRA, H, VALAGUSSA, P, BONADONNA, G
Published in British journal of haematology (01.11.1998)
Published in British journal of haematology (01.11.1998)
Get full text
Journal Article
EP16.03-040 Biomarkersatlas.com: the Italian NSCLC Precision Medicine Knowledge Data Base
Malapelle, U., Pepe, F., Pisapia, P., Righi, L., Listì, A., Reale, M.L., Passiglia, F., Tiseo, M., Genova, C., Galetta, D., Cortinovis, D., Pilotto, S., Migliorino, M.R., Parra, H. Soto, Cappuzzo, F., Novello, S., Troncone, G.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-Positive NSCLC: ALNEO Phase II Trial (GOIRC-01-2020)
Leonetti, A., Minari, R., Boni, L., Gnetti, L., Bordi, P., Verzè, M., Ampollini, L., Gelsomino, F., Toschi, L., Cecere, F., Pilotto, S., Metro, G., Passiglia, F., Cortinovis, D., Guaitoli, G., Pasello, G., Delmonte, A., Mazzoni, F., Bria, E., Galetta, D., Genova, C., Rocco, D., Soto Parra, H., Bearz, A., Migliorino, M.R., Camerini, A., Tognetto, M., Tiseo, M.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
97O First-line pembrolizumab plus chemotherapy for patients with advanced squamous NSCLC: 3-year follow-up from KEYNOTE-407
Robinson, A.G., Vicente, D., Tafreshi, A., Parra, H. Soto, Mazieres, J., Cicin, I., Medgyasszay, B., Rodríguez-Cid, J., Okamoto, I., Lee, S., Ramlau, R., Vladimirov, V., Cheng, Y., Halmos, B., Liu, C-C., Schwarzenberger, P., Piperdi, B., Paz-Ares, L.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
P2.04-11 An IL-8/IFN-gammma/NLR Plasma Score to Predict Nivolumab Efficacy in Patients with NSCLC
Passiglia, F., Russo, A., Ferro, S., Lalli, L., Cova, A., Soto Parra, H., Rivoltini, L., Huber, V.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
P35.14 NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC)
Pilotto, S., Sperduti, I., Sposito, M., Casali, M., Ferrara, M.G., Calvetti, L., Veccia, A., Bonato, A., Sartori, G., Belluomini, L., Vita, E., Cucciniello, L., Inzerilli, N., Parra, H. Soto, Aprile, G., Caffo, O., Scarpa, A., Tortora, G., Bria, E., Milella, M.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
1842OMutational profile of malignant pleural mesothelioma (MPM) in the phase II RAMES study
Pagano, M, Gnoni, R, Bonelli, C, Zanelli, F, Garassino, M C, Ceresoli, G L, Pasello, G, Tiseo, M, Soto Parra, H J, Grosso, F, Zucali, P A, Larocca, M, Torricelli, F, Ciarrocchi, A, Pinto, C
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article